This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Eric A. Pierce, MD, PhD; Eliot D. Foley; Lois E. H. Smith, MD, PhD

Arch Ophthalmol. 1996;114(10):1219-1228.

Abstract
Objectives
To investigate the role of vascular endothelial growth factor (VEGF) in the pathogenesis of the first phase of retinopathy of prematurity (ROP) and to examine the mechanism by which supplemental oxygen therapy might inhibit neovascularization in the second phase of ROP.

Methods
A novel combination of fluorescein-dextran perfusion and colorimetric whole-retina in situ hybridization was used to evaluate the expression of VEGF messenger RNA in relationship to the location of blood vessels in retinas from neonatal mice that were exposed to hyperoxia. Northern blot and immunoblot analyses were used to quantify the changes in VEGF messenger RNA and protein expression caused by hyperoxia. The ability of VEGF to prevent hyperoxia-induced vasoobliteration was evaluated by injecting exogenous VEGF into the vitreous cavity prior to oxygen exposure.

Results
Vascular endothelial growth factor messenger RNA was produced in a reticular pattern just anterior to the developing blood vessels in normal retina on postnatal day 7. The expression of VEGF in the peripheral retina was down-regulated by hyperoxia in conjunction with the arrest of growth and the loss of some of the developing vasculature. Total VEGF messenger RNA and protein levels in retinas from animals on postnatal day 7 were decreased 55% and 85%, respectively, after 6 hours in 75% oxygen. Vaso-obliteration was inhibited 57% by pretreatment of animals with exogenous VEGF. In animals with retinal ischemia secondary to loss of vasculature, treatment with supplemental oxygen therapy decreased stimulated retinal VEGF levels by approximately 70%.

Conclusions
Down-regulation of VEGF expression by hyperoxia may be partly responsible for the vasoobliteration and cessation of normal retinal blood vessel growth observed in premature infants in whom ROP develops. Hyperoxia also has the potential to be used therapeutically to down-regulate VEGF expression in hypoxic retina in the hope of limiting the neovascular complications of ROP. Based on these findings about the regulation of VEGF expression in the retina, an explanation of the pathogenesis of ROP is proposed.

Author Affiliations
From the Departments of Ophthalmology, Children's Hospital and Harvard Medical School, Boston, Mass. Drs Pierce and Smith are members of the V. Kann Rasmussen Research Collaborative.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinopathy of Prematurity: Clinical Insights from Molecular Studies
Heidary et al.
NeoReviews 2009;10:e550-e557.
ABSTRACT | FULL TEXT  

Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy
Sears et al.
Proc. Natl. Acad. Sci. USA 2008;105:19898-19903.
ABSTRACT | FULL TEXT  

Through The Eyes of a Child: Understanding Retinopathy through ROP The Friedenwald Lecture
Smith
IOVS 2008;49:5177-5182.
FULL TEXT  

Anti-vascular endothelial growth factor and retinopathy of prematurity
Sears
Br J Ophthalmol 2008;92:1437-1438.
FULL TEXT  

Human Milk Intake and Retinopathy of Prematurity in Extremely Low Birth Weight Infants
Raghuveer and Belmont
Pediatrics 2008;122:686-687.
FULL TEXT  

N-(4-hydroxyphenyl) Retinamide Augments Laser-Induced Choroidal Neovascularization in Mice
Sreekumar et al.
IOVS 2008;49:1210-1220.
ABSTRACT | FULL TEXT  

Identification of Novel Alternatively Spliced Isoforms of RTEF-1 within Human Ocular Vascular Endothelial Cells and Murine Retina
Appukuttan et al.
IOVS 2007;48:3775-3782.
ABSTRACT | FULL TEXT  

The dipeptide arg-gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu et al.
IOVS 2006;47:3151-3155.
ABSTRACT | FULL TEXT  

Diode laser versus cryotherapy in treatment of ROP.
O'Keefe and Kirwan
Br J Ophthalmol 2006;90:402-403.
FULL TEXT  

Ontogeny of VEGF, IGF-I, and GH in Neonatal Rat Serum, Vitreous Fluid, and Retina from Birth to Weaning
Modanlou et al.
IOVS 2006;47:738-744.
ABSTRACT | FULL TEXT  

Expression and Activation of STAT3 in Ischemia-Induced Retinopathy
Mechoulam and Pierce
IOVS 2005;46:4409-4416.
ABSTRACT | FULL TEXT  

Riluzole Inhibits VEGF-Induced Endothelial Cell Proliferation In Vitro and Hyperoxia-Induced Abnormal Vessel Formation In Vivo
Yoo et al.
IOVS 2005;46:4780-4787.
ABSTRACT | FULL TEXT  

Pigment Epithelium-Derived Factor Is a Substrate for Matrix Metalloproteinase Type 2 and Type 9: Implications for Downregulation in Hypoxia
Notari et al.
IOVS 2005;46:2736-2747.
ABSTRACT | FULL TEXT  

Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes
West et al.
Development 2005;132:1855-1862.
ABSTRACT | FULL TEXT  

Strain-Dependent Differences in Oxygen-Induced Retinopathy in the Inbred Rat
van Wijngaarden et al.
IOVS 2005;46:1445-1452.
ABSTRACT | FULL TEXT  

Impaired Retinal Angiogenesis in Diabetes: Role of Advanced Glycation End Products and Galectin-3
Stitt et al.
Diabetes 2005;54:785-794.
ABSTRACT | FULL TEXT  

Inhibition of Tumor Necrosis Factor-{alpha} Improves Physiological Angiogenesis and Reduces Pathological Neovascularization in Ischemic Retinopathy
Gardiner et al.
Am. J. Pathol. 2005;166:637-644.
ABSTRACT | FULL TEXT  

Microvascular patterning is controlled by fine-tuning the Akt signal
Sun et al.
Proc. Natl. Acad. Sci. USA 2005;102:128-133.
ABSTRACT | FULL TEXT  

Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF
Apte et al.
IOVS 2004;45:4491-4497.
ABSTRACT | FULL TEXT  

Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara
Endocr. Rev. 2004;25:581-611.
ABSTRACT | FULL TEXT  

Genetic Polymorphisms and Retinopathy of Prematurity
Cooke et al.
IOVS 2004;45:1712-1715.
ABSTRACT | FULL TEXT  

Transforming growth factor {beta}1 induction of vascular endothelial growth factor receptor 1: Mechanism of pericyte-induced vascular survival in vivo
Shih et al.
Proc. Natl. Acad. Sci. USA 2003;100:15859-15864.
ABSTRACT | FULL TEXT  

Preliminary Results of Treatment of Eyes With High-Risk Prethreshold Retinopathy of Prematurity in the Early Treatment for Retinopathy of Prematurity Randomized Trial
Fielder
Arch Ophthalmol 2003;121:1769-1771.
FULL TEXT  

Nasotemporal Asymmetry of Retinopathy of Prematurity
Gallagher et al.
Arch Ophthalmol 2003;121:1563-1568.
ABSTRACT | FULL TEXT  

Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite
Gu et al.
Am. J. Physiol. Cell Physiol. 2003;285:C546-C554.
ABSTRACT | FULL TEXT  

The Role of Fas-FasL in the Development and Treatment of Ischemic Retinopathy
Barreiro et al.
IOVS 2003;44:1282-1286.
ABSTRACT | FULL TEXT  

Retinal neovascular markers in retinopathy of prematurity: aetiological implications
North et al.
Br J Ophthalmol 2003;87:275-278.
ABSTRACT | FULL TEXT  

Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants?
Chow et al.
Pediatrics 2003;111:339-345.
ABSTRACT | FULL TEXT  

ERK5 MAPK Regulates Embryonic Angiogenesis and Acts as a Hypoxia-sensitive Repressor of Vascular Endothelial Growth Factor Expression
Sohn et al.
J. Biol. Chem. 2002;277:43344-43351.
ABSTRACT | FULL TEXT  

Retinopathy of Prematurity Outcome in Infants With Prethreshold Retinopathy of Prematurity and Oxygen Saturation >94% in Room Air: The High Oxygen Percentage in Retinopathy of Prematurity Study
McGregor et al.
Pediatrics 2002;110:540-544.
ABSTRACT | FULL TEXT  

IGF-I Is Critical for Normal Vascularization of the Human Retina
Hellstrom et al.
J. Clin. Endocrinol. Metab. 2002;87:3413-3416.
ABSTRACT | FULL TEXT  

Localization of VEGF Receptor-2 (KDR/Flk-1) and Effects of Blocking It in Oxygen-Induced Retinopathy
McLeod et al.
IOVS 2002;43:474-482.
ABSTRACT | FULL TEXT  

Effects of Sustained Hyperoxia on Revascularization in Experimental Retinopathy of Prematurity
Gu et al.
IOVS 2002;43:496-502.
ABSTRACT | FULL TEXT  

Regulation of Matrix Metalloproteinase Expression by Tumor Necrosis Factor in a Murine Model of Retinal Neovascularization
Majka et al.
IOVS 2002;43:260-266.
ABSTRACT | FULL TEXT  

The {alpha}1{beta}1 and {alpha}2{beta}1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis
Senger et al.
Am. J. Pathol. 2002;160:195-204.
ABSTRACT | FULL TEXT  

An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration
Lahdenranta et al.
Proc. Natl. Acad. Sci. USA 2001;98:10368-10373.
ABSTRACT | FULL TEXT  

Ten-Year Follow-up From the CRYO-ROP Study
Tasman
Arch Ophthalmol 2001;119:1200-1201.
FULL TEXT  

Captopril Improves Retinal Neovascularization via Endothelin-1
Tadesse et al.
IOVS 2001;42:1867-1872.
ABSTRACT | FULL TEXT  

C-Abl Is Required for the Development of Hyperoxia-Induced Retinopathy
Nunes et al.
JEM 2001;193:1383-1392.
ABSTRACT | FULL TEXT  

Colocalization of Neuropilin-1 and Flk-1 in Retinal Neovascularization in a Mouse Model of Retinopathy
Ishihama et al.
IOVS 2001;42:1172-1178.
ABSTRACT | FULL TEXT  

Response of Experimental Retinal Neovascularization to Thiazolidinediones
Murata et al.
Arch Ophthalmol 2001;119:709-717.
ABSTRACT | FULL TEXT  

Glucose, VEGF-A, and Diabetic Complications
Benjamin
Am. J. Pathol. 2001;158:1181-1184.
FULL TEXT  

Reduced Severity of Oxygen-Induced Retinopathy in eNOS-Deficient Mice
Brooks et al.
IOVS 2001;42:222-228.
ABSTRACT | FULL TEXT  

A Novel Model of Retinopathy of Prematurity Simulating Preterm Oxygen Variability in the Rat
Cunningham et al.
IOVS 2000;41:4275-4280.
ABSTRACT | FULL TEXT  

Diode laser treatment of posterior retinopathy of prematurity
Axer-Siegel et al.
Br J Ophthalmol 2000;84:1383-1386.
ABSTRACT | FULL TEXT  

STOP-ROP Results Suggest Selective Use of Supplemental Oxygen for Prethreshold ROP
Arch Ophthalmol 2000;118:1121-1122.
FULL TEXT  

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes
The STOP-ROP Multicenter Study Group
Pediatrics 2000;105:295-310.
ABSTRACT | FULL TEXT  

Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson et al.
Science 1999;285:245-248.
ABSTRACT | FULL TEXT  

Expression of Thrombospondin-1 in Ischemia-Induced Retinal Neovascularization
Suzuma et al.
Am. J. Pathol. 1999;154:343-354.
ABSTRACT | FULL TEXT  

Vascular endothelial growth factor (VEGF) and its receptors
Neufeld et al.
FASEB J. 1999;13:9-22.
ABSTRACT | FULL TEXT  

Light Exposure Is Not Associated With Retinopathy of Prematurity
Mills
Arch Ophthalmol 1998;116:1517-1518.
FULL TEXT  

Ocular Neovascularization : Clarifying Complex Interactions
Neely and Gardner
Am. J. Pathol. 1998;153:665-670.
FULL TEXT  

Systemic Hyperoxia Decreases Vascular Endothelial Growth Factor Gene Expression in Ischemic Primate Retina
Pournaras et al.
Arch Ophthalmol 1997;115:1553-1558.
ABSTRACT  

Role of vascular permeability factor/vascular endothelial growth factor in eye disease
SCHLINGEMANN and VAN HINSBERGH
Br J Ophthalmol 1997;81:501-512.
FULL TEXT  

Vascular Endothelial Growth Factor and the Eye: Past, Present, and Future
Aiello
Arch Ophthalmol 1996;114:1252-1254.
ABSTRACT  

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity
Hellstrom et al.
Proc. Natl. Acad. Sci. USA 2001;98:5804-5808.
ABSTRACT | FULL TEXT